Clinical trials
Withdrawn Phase 3 trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Celgene | 2 |
| Medical University of Vienna | 2 |
| Johannes Laengle, MD, PhD | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| Marinus Pharmaceuticals | 1 |
| Medical University Innsbruck | 1 |
| Novartis Pharmaceuticals | 1 |
| Novo Nordisk A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colonic Neoplasms | 1 |
| Crohn Disease | 1 |
| Depressive Disorder, Treatment-Resistant | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Dry Eye Syndromes | 1 |
| Giant Cell Arteritis | 1 |
| Humeral Fractures | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Lung Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.